Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas

Patients: Soft tissue sarcomas are uncommon malignancies with few therapeutic options for recurrent or metastatic disease. Dolastatin-10 (Dol-10) is a pentapeptide anti-microtubule agent that binds to tubulin sites distinct from vinca alkaloids. Based on the novel mechanism of action, limited activi...

詳細記述

保存先:
書誌詳細
主要な著者: von Mehren, M., Balcerzak, S. P., Kraft, A. S., Edmonson, J. H., Okuno, S. H., Davey, M., Mclaughlin, S., Beard, M. T., Rogatko, A.
フォーマット: Artigo
言語:Inglês
出版事項: Sarcoma 2004
主題:
Case Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395616/
https://ncbi.nlm.nih.gov/pubmed/18521404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2004/924913
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料